Literature DB >> 10704975

The influence of the timing of administration of thiopentone sodium on nitric oxide-mediated neurotoxicity in vitro.

S Shibuta1, J Kosaka, T Inoue, T Shimizu, K Tomi, T Mashimo.   

Abstract

Thiopentone sodium is a highly useful pharmacological agent that provides a neuroprotection against cerebral ischaemia. Since not all patients can receive thiopentone sodium before cerebral ischaemia occurs, we investigated the influence of timing of thiopentone sodium administration on the neurotoxicity induced by nitric oxide (NO) using Shibuta's established model of primary brain cultures. Cortical neurones prepared from 16-day gestational rat foetuses were used after 13-14 days in culture. The cells were exposed to an NO-donor, NOC-5 at 30 microM. Thiopentone sodium administered at 30 and 10 min before or 5, 10 and 15 min after exposure to NOC-5, but not thereafter, significantly attenuated NO-induced neurotoxicity compared with controls. The survival rate of the neurones in which thiopentone sodium was administered at 15 min after exposure to NOC-5 was 55.7+/-2.4%, compared to a 10.0+/-1.6% survival rate in neurones when thiopentone sodium was administered at 30 min after exposure to NOC-5. These findings demonstrate that thiopentone sodium, which protects cerebral cortical neurones against NO-mediated cytotoxicity, should be given as soon as possible in case ischaemic or hypoxic neuronal damage is predicted.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10704975     DOI: 10.1016/s0022-510x(99)00324-x

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  2 in total

1.  Protective effects of the free radical scavenger edaravone against glutamate neurotoxicity in nearly pure neuronal culture.

Authors:  Kenjiro Hisano; Masahiko Watanabe; Yuji Morimoto
Journal:  J Anesth       Date:  2009-08-14       Impact factor: 2.078

2.  Effect of preconditioning on propofol-induced neurotoxicity during the developmental period.

Authors:  Satoshi Shibuta; Tomotaka Morita; Jun Kosaka
Journal:  PLoS One       Date:  2022-08-19       Impact factor: 3.752

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.